Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease

Painchart, C; Brabant, S; Duveau, N; Nachury, M; Desreumaux, P; Branche, J; Gerard, R; Prevost, CLD; Wils, P; Lambin, T; Boualit, M; Labalette, M; Pariente, B

Pariente, B (corresponding author), Univ Lille, Gastroenterol Dept, CHRU Lille, Lille, France.; Pariente, B (corresponding author), Inserm Unit 995, Lille, France.

DIGESTIVE DISEASES AND SCIENCES, 2020; 65 (5): 1445

Abstract

Introduction The aim of this study was to evaluate the association between serum ustekinumab (UST) trough levels and response to induction and mainten......

Full Text Link